Biora Therapeutics (BIOR) Stock Chart & Stock Price History $0.16 0.00 (-2.79%) As of 03/14/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrends Biora Therapeutics Stock Price Performance 5 Day Performance+29.98%1 Month Performance+30.61%3 Month Performance-74.54%6 Month Performance-97.54%Year-To-Date Performance-27.27%1 Year Performance-98.61% Receive BIOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BIOR Stock Chart for Tuesday, March, 18, 2025 BIOR Chart by TradingViewRemove Ads Biora Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/17/2025$0.16$0.16$0.16$0.1219,488 shs$724,000.0003/14/2025$0.12$0.12$0.16$0.124,411 shs$557,000.0003/13/2025$0.12$0.12+0.90%$0.16$0.124,411 shs$557,000.0003/12/2025$0.12$0.12+3.92%$0.16$0.1239,808 shs$552,000.0003/11/2025$0.12$0.12$0.17$0.128,959 shs$531,000.0003/10/2025$0.12$0.12$0.17$0.128,959 shs$531,000.0003/07/2025$0.14$0.13-10.26%$0.17$0.1372,801 shs$570,000.0003/06/2025$0.14$0.14$0.17$0.1423,747 shs$635,000.0003/05/2025$0.14$0.14+0.29%$0.17$0.1423,747 shs$635,000.0003/04/2025$0.14$0.14$0.17$0.1311,023 shs$633,000.00 Get the Latest News and Ratings for BIOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/03/2025$0.14$0.14$0.17$0.1311,023 shs$633,000.0002/28/2025$0.13$0.13-1.22%$0.17$0.1142,889 shs$567,000.0002/27/2025$0.11$0.13+13.65%$0.17$0.136,102 shs$574,000.0002/26/2025$0.17$0.11-34.29%$0.18$0.0863,678 shs$505,000.0002/25/2025$0.12$0.17+41.67%$0.18$0.1289,158 shs$769,000.0002/24/2025$0.12$0.12$0.16$0.1214,214 shs$543,000.0002/21/2025$0.13$0.13$0.13$0.1223,714 shs$588,000.0002/20/2025$0.13$0.13$0.13$0.1223,714 shs$588,000.0002/19/2025$0.12$0.13+6.12%$0.18$0.1260,244 shs$588,000.0002/18/2025$0.12$0.12$0.15$0.124,405 shs$554,000.0002/17/2025$0.12$0.12$0.15$0.124,405 shs$554,000.00 Related Companies Avenue Therapeutics Stock Chart Protagenic Therapeutics Stock Chart Galera Therapeutics Stock Chart Cyclacel Pharmaceuticals Stock Chart Vincerx Pharma Stock Chart Shuttle Pharmaceuticals Stock Chart Panbela Therapeutics Stock Chart Kiromic BioPharma Stock Chart Salarius Pharmaceuticals Stock Chart Oncternal Therapeutics Stock Chart Receive BIOR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIOR) was last updated on 3/18/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIs 2025 really the best time to get rich in American history?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored92% win rate – even whe the market crashesMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
